Verrica Pharmaceuticals Inc. Common Stock

AED20.86
AED
Last updated on --.
24h volume15.56K
24h highest22.3820 AED
24h lowest20.6411 AED
24h Price movement+0.89%

VRCA recent prices

24 Hours
+0.89%+AED0.18364
30 days
-6.27%-AED1.396
60 days
-12.68%-AED3.031
90 days
+17.11%+AED3.048

Key data

Previous close20.6779 AED
Market cap361.53M AED
Volume15.56K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.8197 AED
Net income (FY)-65.47M AED
Revenue (FY)136.48M AED
Last report dateMay 12, 2026

About Verrica Pharmaceuticals Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersWEST CHESTER
Employees (FY)76.00
Revenue per employee (FY)1.80M AED
Net income per employee (FY)-861.46K AED
Listed onNasdaq
Official website

VRCA conversion tables

VRCAVRCA
AEDAED
0.5 VRCA10.43 AED
1 VRCA20.86 AED
5 VRCA104.3 AED
10 VRCA208.61 AED
AEDAED
VRCAVRCA
0.5 AED0.023968 VRCA
1 AED0.047935 VRCA
5 AED0.23968 VRCA
10 AED0.47935 VRCA

FAQ

VRCA is trading at AED20.86, +0.89% over the last 24 hours. Track live moves on the price chart at the top of this page.
The VRCA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. VRCA is currently trading at AED20.86, +0.89% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on VRCA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. VRCA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from VRCA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against VRCA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Verrica Pharmaceuticals Inc. Common Stock's market cap is currently 361.53M AED. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume15.56K
24h highest22.3820 AED
24h lowest20.6411 AED
24h Price movement+0.89%
VRCAVRCA
AEDAED
Start trade with VRCA Perpetual